Use double quotes to find documents that include the exact phrase: "aerodynamic AND testing"

CCES – (Ottawa, Ontario – July 28, 2016) – The Canadian Centre for Ethics in Sport (CCES) announced today that Emma Woodhouse, an alpine skier, has committed an anti-doping rule violation and has received a sanction of a reprimand. The athlete’s urine sample, collected during in-competition doping control on March 28, 2016, revealed the presence of methylphenidate, a prohibited stimulant.  

Methylphenidate is classified as a “specific substance” on the World Anti-Doping Agency Prohibited List, banned in-competition. Under the rules of the Canadian Anti-Doping Program (CADP), an athlete facing a first violation involving a “specified substance” can seek to have the sanction reduced to a reprimand. Based on factors assessed, including the athlete’s degree of fault, the CCES proposed a sanction of a reprimand and no period of ineligibility.

In response to the CCES’ notification of the adverse analytical finding, Ms. Woodhouse waived her right to a hearing, acknowledged the anti-doping rule violation, and accepted the sanction of a reprimand proposed by the CCES.

In compliance with rule 7.10 of the CADP, a copy of the CCES’ file outcome summary can be found at:

The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.

— 30 —

For further information, please contact:
Justin MacNeill
Communications Coordinator
+1 613-521-3340 x3314